The trademark application EPICHECK was filed by Nucleix Limited, a corporation established under the laws of the State of Israel (the "Applicant"). Application under examination.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 1 with Diagnostic preparations for laboratory use, namely, for forensic laboratory use in the field of cancer detection.
The mark was filed in class 5 with following description of goods:
Diagnostic test kits for medical and clinical use comprising markers for use in identifying and measuring changes associated with cancer or precancerous conditions
Assay kit comprising markers for use in identifying and measuring changes associated with cancer or precancerous conditions
Medical diagnostic kits for use in the field of cancer detection
Markers and/or buffers, sold separately or in laboratory kit form, using epigenetic markers for diagnosis of cancer.
The mark was filed in class 9 with Software for analyzing the results of biochemical assays for detection of cancer.
The mark was filed in class 10 with Clinical and medical laboratory (in vitro) medical testing apparatus for diagnosing cancer, in particular ones containing biochemical markers.
The mark was filed in class 42 with Pharmaceutical drug research and development, consulting services in the fields of biotechnology and custom assay development, all in the field of cancer and pre-cancerous conditions..
The mark was filed in class 44 with following description of goods:
Consulting services in the field of health
Consulting services in the field of diagnostic medical testing
Medical analysis for the diagnosis of the cancer and prognosis of expected progression of the disease
Medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer
Providing cancer screening services
Providing a website featuring information on the signs and symptoms of cancer, causes of cancer, risk factors for cancer.